CAPILLARY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Capillary Technologies India Limited announced its audited standalone and consolidated financial results for Q4 and full year ended March 31, 2026. Standalone revenue from operations grew 21.7% year-on-year to ₹2,118.90 million from ₹1,740.91 million. However, profit before tax declined to ₹28.90 million from ₹35.06 million in the previous year. The Board also appointed M/s. Protiviti India Member Private Limited as Internal Auditors for FY 2026-27. The statutory auditor Walker Chandiok & Co. LLP issued an unmodified opinion on the financial statements. The company completed its IPO in November 2025, raising ₹8,775.01 million, with net proceeds of ₹3,229.08 million pending utilization (₹3,228.95 million invested in fixed deposits as of March 2026). Trading window was closed from April 1, 2026 and will reopen 48 hours after the results declaration.
The revenue growth is positive, showing business expansion, but the decline in profitability despite higher revenues may raise concerns about cost management. The appointment of Protiviti India as internal auditor indicates a change in internal audit arrangements, which investors should monitor for any underlying reasons.